|Videos|July 16, 2016

How Should Practitioners Test for the Colistin-Resistant mcr-1 Gene?

Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, discusses how practitioners should test for colistin-resistant pathogens.

Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, discusses how practitioners should test for colistin-resistant pathogens.

Interview Transcript (slightly modified for readability)

“We have to distinguish two situations, infection, and colonization. In the case of [an] infection, we are able to detect these mechanisms, or at least we have a suspicion of these mcr-1 mechanism of resistance, because when we detect an isolate, an Escherichia coli [or] a Klebsiella in the clinical laboratory, we preform the antibiotic susceptibility test, and usually we [also] test [for] colistin [resistance], so we can see that the bacteria are resistant to colistin.

A major problem is the second situation, when the patients are only colonized at [the] intestinal level. Since we don’t have a lot of these bacteria [at] the intestinal level, there is a tiny quantity, we need to use [specific] systems to detect them. We can use culture-systems, selective plates that contain colistin to see if [the bacteria] grow in the plates, and then we can [molecularly characterize] them. [As an alternative mechanism of detection], we can [test] the stools of patients, through a rectal swab, with molecular tests. For example, [we can use] real-time PCR that is already described in the literature, to detect the mcr-1 gene. [It is] very [probable that] the performance of the real-time PCR is a little bit better than the culture approach.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
FAQ: XDR Shigella
Here is some important information around this pathogen and the intestinal infection.